Corbus Pharmaceuticals Holdings, Inc. (CRBP)
3.94
+0.42
(+11.93%)
USD |
NASDAQ |
Nov 10, 16:00
3.94
0.00 (0.00%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Cash from Operations (Annual) : -64.49M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -64.49M |
| December 31, 2024 | -41.79M |
| December 31, 2023 | -36.10M |
| December 31, 2022 | -37.54M |
| December 31, 2021 | -48.18M |
| December 31, 2020 | -99.69M |
| December 31, 2019 | -45.72M |
| Date | Value |
|---|---|
| December 31, 2018 | -30.07M |
| December 31, 2017 | -27.80M |
| December 31, 2016 | -13.57M |
| December 31, 2015 | -4.625M |
| December 31, 2014 | -2.348M |
| December 31, 2013 | -0.3667M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Heron Therapeutics, Inc. | -27.59M |
| Tonix Pharmaceuticals Holding Corp. | -99.84M |
| Karyopharm Therapeutics, Inc. | -75.37M |
| Minerva Neurosciences, Inc. | -13.51M |
| Ocugen, Inc. | -56.96M |